Fosmore Clifford L, Sullivan Stephen, Brouwer Andrew F, Goold Susan D, Reisner Sari L, Fendrick A Mark, Harper Diane M
University of Michigan, 1018 Fuller Street, Ann Arbor, MI, 48105, USA.
University of Michigan Medical School, Ann Arbor, MI, USA.
J Gen Intern Med. 2024 Dec;39(16):3333-3338. doi: 10.1007/s11606-024-09026-9. Epub 2024 Sep 23.
Self-sampling for primary HPV detection for cervical cancer screening is now FDA-approved. Many persons interested in cervical cancer screening are eager to opt out of the invasive speculum exam and opt into the self-sampling. There is no limitation on which persons can choose self-sampling. Transgender, nonbinary, and gender-diverse assigned female at birth (TGD AFAB) people experience barriers such as gender dysphoria and discomfort with sensitive exams. They may find more comfort with this equivalent method of screening. However, no clinical guidelines describe the best practices to increase screening among this underserved population. Much community work needs to occur to make the language of screening gender-affirming for all participants. Solutions to currently invasive follow-up exams after abnormal screens need to be communicated in language directed by the TGD AFAB community.
用于宫颈癌筛查的人乳头瘤病毒(HPV)初筛的自我采样现已获得美国食品药品监督管理局(FDA)批准。许多对宫颈癌筛查感兴趣的人都渴望避开侵入性的窥器检查,选择自我采样。对于哪些人可以选择自我采样没有限制。出生时被指定为女性的跨性别者、非二元性别者和性别多样化者(TGD AFAB)会遇到诸如性别焦虑和对敏感检查感到不适等障碍。他们可能会对这种等效的筛查方法感到更舒适。然而,没有临床指南描述在这个未得到充分服务的人群中增加筛查的最佳做法。需要开展大量社区工作,以使筛查语言对所有参与者都具有性别肯定性。异常筛查后目前侵入性后续检查的解决方案需要用TGD AFAB社区指导的语言进行传达。